Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia?

Detalles Bibliográficos
Autores principales: Swaminathan, Mahesh, Ravandi, Farhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543186/
https://www.ncbi.nlm.nih.gov/pubmed/37345488
http://dx.doi.org/10.3324/haematol.2023.283120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543186/
https://www.ncbi.nlm.nih.gov/pubmed/37345488
http://dx.doi.org/10.3324/haematol.2023.283120

Ejemplares similares